{"id":616349,"title":"Notice of Intent to Amend the Prescription Drug List (PDL): Brimonidine  - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-02","captureTimestamp":"2026-03-02T19:37:31.241000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/intent-amend-brimonidine.html","snippet":"Notice of Intent to Amend the Prescription Drug List (PDL): Brimonidine November 15, 2021 Our file number: 21-119262-176 The purpose of this Notice of Intent to Amend is to notify the revision of brimonidine or its salts on the Prescription Drug List (PDL), by adding a qualifier.…","rawSnapshotUrl":"/api/snapshots/raw/616349","browseUrl":"https://replay.healtharchive.ca/job-6/20260302193731/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/intent-amend-brimonidine.html#ha_snapshot=616349","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}